secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2025-02-05T23:59:59+00:00
Accession:  0001174947-25-000129
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q4 2024 sales $345.9M (+5.8% YoY), adjusted EPS $1.34; FY25 guidance issued
--------------------------------------------------------------------------------

- Q4 GAAP diluted EPS $1.08 (vs $1.05 YoY); adjusted diluted EPS $1.34 (+26.4%).
- Full-year 2024 sales $1,307.0M (+5.0% reported); adjusted EPS $4.17 vs $3.45 in 2023.
- Q4 single-use product sales +9.6% YoY; capital product sales declined 12.7%.
- FY2025 guidance: revenue $1.344-1.372B (4-6% constant currency growth); adjusted EPS $4.25-4.40.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000117494725000129/0001174947-25-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000117494725000129/form8k-33496_cnmd.htm
  HTML page:      https://secwatch.observer/filing/0001174947-25-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer